Uplisting, as a priority is not even in question in LP's strategy going forward. She hired two uplisting specialists a few years ago in preparation for what's an inevitability. She also made corporate structuring changes since then, and folded Advent under NWBO, to create a fully integrated business under super favorable terms which benefits shareholders. These are the actions of a company fully intent on uplisting. We learned about another critically valuable Kalinsky patent recently issued, and it's importance to the DCVAX platform cannot be overstated.
That's what I'm focused on period. The contrived noise would have had some bearing on my concerns had these remarkable ongoing accomplishments only been old stale news of years past. But it's the complete opposite under heavy manipulation, which is pretty amazing to behold IMHO.
Market Data 
Markets 
AI
